Biotechnology Services
|
US$
300 |
Jan-2025 |
Doc #41539 |
|
Printed Page Length :
17
pages |
Number of Tables :
1 |
Number of Figures:
1 |
Market Overview
|
Government-backed initiatives to support the biomedical sector, coupled with enhanced regulatory compliance and the return of domestic medical capacity to pre-pandemic levels, are poised to optimize the operations of local clinical and preclinical CRO and CDMO firms. These favorable conditions are expected to propel continued growth in Taiwan's biotechnology services industry in 2025.
|
|
|